Tenofovir disoproxil fumarate versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis.

Wang Y, Wu JY, Xiang Q, Liao TF, Jiang XY, Chen J

Open source

DOI
10.3389/fonc.2025.1462794
Published
2025
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2025.1462794,
  title = {Tenofovir disoproxil fumarate versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis.},
  author = {Wang Y and Wu JY and Xiang Q and Liao TF and Jiang XY and Chen J},
  year = {2025},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2025.1462794},
  url = {https://doi.org/10.3389/fonc.2025.1462794}
}

RIS

TY  - JOUR
TI  - Tenofovir disoproxil fumarate versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis.
AU  - Wang Y
AU  - Wu JY
AU  - Xiang Q
AU  - Liao TF
AU  - Jiang XY
AU  - Chen J
PY  - 2025
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2025.1462794
UR  - https://doi.org/10.3389/fonc.2025.1462794
ER  - 

APA

Y, W., JY, W., Q, X., TF, L., XY, J., & J, C. (2025). Tenofovir disoproxil fumarate versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis.. Frontiers in oncology. https://doi.org/10.3389/fonc.2025.1462794

Source records